Interviews and Focus Groups for Cancer Treatment Access

Overseen By John Lin, MD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: M.D. Anderson Cancer Center

Disqualifiers: Cognitive impairment, Pregnancy

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

120 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial uses semi-structured interviews and focus groups to determine facilitators and barriers of receiving timely cancer treatment among multiple cancers, across multiple insurance types, throughout Texas

Who Is on the Research Team?

John Lin, MD

Principal Investigator

M.D. Anderson Cancer Center

Are You a Good Fit for This Trial?

This trial is for Texas residents who have been diagnosed with cancer. It aims to understand the factors that help or hinder timely cancer treatment across various types of cancers and insurance plans.

Inclusion Criteria

I speak either English or Spanish.

I am 18 years old or older.

Verbal consent will be obtained

Exclusion Criteria

Patients who are cognitively impaired

Pregnant women

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Data Collection

Participants engage in semi-structured interviews and focus groups to assess barriers and facilitators to cancer treatment

6 months

Follow-up

Participants are monitored for safety and effectiveness after data collection

6 months

What Are the Treatments Tested in This Trial?

Interventions

• Focus Groups
• Interviews

Trial Overview The study uses interviews and focus groups to gather information on what makes it easier or harder for people in Texas to get cancer treatment quickly, considering different cancers and insurance coverage.

How Is the Trial Designed?

Group I: Semi-structured Interview Experimental Treatment 1 Intervention

Participants will be recruited through the Texas Cancer Registry (TCR).

Group II: Online Focus Group Experimental Treatment 1 Intervention

Participants will be recruited through the Texas Cancer Registry (TCR).

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials

3,107

Recruited

1,813,000+